Скачать или смотреть Facial Fillers Boom & Danger

1. Explain the "two-tiered cake" analogy for understanding facial anatomy layers.
2. What is the Superficial Musculoaponeurotic System (SMAS), and what is its primary function relevant to facial injections?
3. Describe the location and significance of the prezygomatic space as an injection target.
4. Define vascular occlusion and list two of its immediate signs during an injection procedure.
5. What is Hyaluronic Acid (HA), and what is a major advantage of using it as a facial filler?
6. Why should injectors be cautious when performing superficial volumization of the upper midface?
7. Describe the "fanning" injection technique and identify an area where it is commonly used.
8. What is the Tyndall effect, and what causes it?
9. Why are the glabella and nasolabial fold considered high-risk areas for vascular occlusion?
10. According to the sources, what is a key difference in risk between using a needle and a cannula for filler injections?
--------------------------------------------------------------------------------
Answer Key
1. The "two-tiered cake" analogy conceptualizes the layered anatomy of the face. The facial skeleton is the platter, the middle layer of icing is the SMAS, the layer of cake below it represents the sub-SMAS structures (deep fat, potential spaces), and the layer of cake above it represents the supra-SMAS (subcutaneous) layer, topped by the skin.
2. The Superficial Musculoaponeurotic System (SMAS) is a vestigial remnant of pan-facial muscles that acts as a highway for important structures like vessels and motor nerves. For injectors, understanding the SMAS is crucial because the facial vasculature has an intimate relationship with it, allowing practitioners to navigate superficial and deep to it to potentially avoid vascular injury.
3. The prezygomatic space is a potential gliding space in the upper sub-SMAS midface, located between the suborbicularis oculi fat (SOOF) and the preperiosteal fat pad. It is a desirable and well-described target for deep augmentation and volume restoration of the lateral cheek.
4. Vascular occlusion occurs when blood can no longer pass through a blood vessel, either completely or partially, due to internal obstruction (like filler material) or external compression. Two immediate signs are severe or escalating pain at the time of injection and blanching (a pale, white, or dusky appearance) of the skin in the affected area.
5. Hyaluronic acid (HA) is a naturally occurring substance in the body and the most popular type of facial filler. A major advantage of using HA fillers is their reversibility; they can be dissolved by injecting hyaluronidase, which is critical for managing complications like vascular occlusion.
6. Injectors should be cautious with superficial volumization of the upper midface, specifically between the cutaneous insertions of the orbital retaining ligament and the zygomaticocutaneous ligament. This area contains the superficial lateral chain of lymphatics, and disruption of this chain can be a contributing factor to iatrogenic malar mounds.
7. The fanning technique involves making multiple linear passes of filler along the same plane over an area without withdrawing the needle or cannula from the tissue. This technique is employed to distribute filler over larger areas and can be useful for the deep malar region and the nasolabial fold.
8. The Tyndall effect is a complication that results in a bluish-gray discoloration of the skin overlying an injection site. It is caused by the superficial placement of a hyaluronic acid filler, which causes light to scatter differently over the area containing the material, and is most likely to occur in areas of thin skin like the lower eyelid.
9. The glabella and nasolabial fold are high-risk areas due to their complex and dense vascular anatomy. The glabellar region has a poor collateral circulation, while the facial artery runs in close proximity to the nasolabial fold before becoming the angular artery.
10. A key difference in risk is that needle injections have a higher risk of vascular occlusion compared to cannula injections. A retrospective study found 77.1% lower odds of vascular occlusion with a cannula. Cannulas are less likely to penetrate vessels, while needles have a higher risk of vascular injury.